Polyunsaturated fatty acid in treatment resistant depression: A pilot study

Introduction The deficiency of polyunsaturated fatty acids (PUFAs) and an alteration between the ratio of omega-6 and omega-3 PUFAs may contribute to the pathogenesis of depressive disorders. Objectives To investigate the levels of omega-3 and omega-6 in red cell membranes (mPUFAs) and plasma (p...

Full description

Bibliographic Details
Main Authors: T. Jannini, L. Longo, Y. Barone, C. Niolu, S. Bernardini, A. Siracusano, P. Bertucci, G. Di Lorenzo
Format: Article
Language:English
Published: Cambridge University Press 2021-04-01
Series:European Psychiatry
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S0924933821008683/type/journal_article
_version_ 1827753806987788288
author T. Jannini
L. Longo
Y. Barone
C. Niolu
S. Bernardini
A. Siracusano
P. Bertucci
G. Di Lorenzo
author_facet T. Jannini
L. Longo
Y. Barone
C. Niolu
S. Bernardini
A. Siracusano
P. Bertucci
G. Di Lorenzo
author_sort T. Jannini
collection DOAJ
description Introduction The deficiency of polyunsaturated fatty acids (PUFAs) and an alteration between the ratio of omega-6 and omega-3 PUFAs may contribute to the pathogenesis of depressive disorders. Objectives To investigate the levels of omega-3 and omega-6 in red cell membranes (mPUFAs) and plasma (pPUFAs) of patients with treatment-resistant (TRD) and non-treatment resistant depression (non-TRD). Methods TRD and non-TRD consisted of 75 patients enrolled at the Psychiatric and Clinic Psychology Unit of the University of Rome Tor Vergata, Rome, Italy, and met the DSM-IV criteria for major depressive disorder (MDD). A group of healthy controls (HC) matched for agender and age was enrolled. All blood samples were performed in conditions of an empty stomach between 07:00 am and 09:00 am. For each subject were obtained 5 ml of whole blood with the use of tubes for plasma with EDTA as an anticoagulant. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for omega-3 and arachidonic acid (AA) for omega-6 were measured. Results Levels of pPUFAs did not differ between the three groups. The mPUFAs were altered in the MDD. TRD and non-TRD had lower EPA and AA values respect to the HC. DHA in red cell membranes was lower in TRD than non-TRD and HC. Conclusions Changes in levels of PUFAs in red cell membranes, but not in plasma, may be an important factor to evaluate the resistance to the pharmacological treatment.
first_indexed 2024-03-11T07:40:22Z
format Article
id doaj.art-b8f08b9221e1434c8ec64b464b198fe1
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:40:22Z
publishDate 2021-04-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-b8f08b9221e1434c8ec64b464b198fe12023-11-17T05:08:38ZengCambridge University PressEuropean Psychiatry0924-93381778-35852021-04-0164S323S32410.1192/j.eurpsy.2021.868Polyunsaturated fatty acid in treatment resistant depression: A pilot studyT. Jannini0L. Longo1Y. Barone2C. Niolu3S. Bernardini4A. Siracusano5P. Bertucci6G. Di Lorenzo7Department Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDepartment Of Systems Medicine, University of Rome Tor Vergata, Rome, Italy Introduction The deficiency of polyunsaturated fatty acids (PUFAs) and an alteration between the ratio of omega-6 and omega-3 PUFAs may contribute to the pathogenesis of depressive disorders. Objectives To investigate the levels of omega-3 and omega-6 in red cell membranes (mPUFAs) and plasma (pPUFAs) of patients with treatment-resistant (TRD) and non-treatment resistant depression (non-TRD). Methods TRD and non-TRD consisted of 75 patients enrolled at the Psychiatric and Clinic Psychology Unit of the University of Rome Tor Vergata, Rome, Italy, and met the DSM-IV criteria for major depressive disorder (MDD). A group of healthy controls (HC) matched for agender and age was enrolled. All blood samples were performed in conditions of an empty stomach between 07:00 am and 09:00 am. For each subject were obtained 5 ml of whole blood with the use of tubes for plasma with EDTA as an anticoagulant. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for omega-3 and arachidonic acid (AA) for omega-6 were measured. Results Levels of pPUFAs did not differ between the three groups. The mPUFAs were altered in the MDD. TRD and non-TRD had lower EPA and AA values respect to the HC. DHA in red cell membranes was lower in TRD than non-TRD and HC. Conclusions Changes in levels of PUFAs in red cell membranes, but not in plasma, may be an important factor to evaluate the resistance to the pharmacological treatment. https://www.cambridge.org/core/product/identifier/S0924933821008683/type/journal_articlefatty acidsTreatment Resistant Depressionomega3omega6
spellingShingle T. Jannini
L. Longo
Y. Barone
C. Niolu
S. Bernardini
A. Siracusano
P. Bertucci
G. Di Lorenzo
Polyunsaturated fatty acid in treatment resistant depression: A pilot study
European Psychiatry
fatty acids
Treatment Resistant Depression
omega3
omega6
title Polyunsaturated fatty acid in treatment resistant depression: A pilot study
title_full Polyunsaturated fatty acid in treatment resistant depression: A pilot study
title_fullStr Polyunsaturated fatty acid in treatment resistant depression: A pilot study
title_full_unstemmed Polyunsaturated fatty acid in treatment resistant depression: A pilot study
title_short Polyunsaturated fatty acid in treatment resistant depression: A pilot study
title_sort polyunsaturated fatty acid in treatment resistant depression a pilot study
topic fatty acids
Treatment Resistant Depression
omega3
omega6
url https://www.cambridge.org/core/product/identifier/S0924933821008683/type/journal_article
work_keys_str_mv AT tjannini polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT llongo polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT ybarone polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT cniolu polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT sbernardini polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT asiracusano polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT pbertucci polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy
AT gdilorenzo polyunsaturatedfattyacidintreatmentresistantdepressionapilotstudy